Amedisys Other Long-Term Assets 2010-2024 | AMED
Amedisys other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
Amedisys Annual Other Long-Term Assets
(Millions of US $) |
| 2023 |
$85 |
| 2022 |
$80 |
| 2021 |
$73 |
| 2020 |
$33 |
| 2019 |
$55 |
| 2018 |
$54 |
| 2017 |
$49 |
| 2016 |
$38 |
| 2015 |
$33 |
| 2014 |
$33 |
| 2013 |
$26 |
| 2012 |
$19 |
| 2011 |
$24 |
| 2010 |
$22 |
| 2009 |
$18 |
Amedisys Quarterly Other Long-Term Assets
(Millions of US $) |
| 2024-09-30 |
$88 |
| 2024-06-30 |
$87 |
| 2024-03-31 |
$86 |
| 2023-12-31 |
$85 |
| 2023-09-30 |
$84 |
| 2023-06-30 |
$85 |
| 2023-03-31 |
$78 |
| 2022-12-31 |
$80 |
| 2022-09-30 |
$81 |
| 2022-06-30 |
$85 |
| 2022-03-31 |
$85 |
| 2021-12-31 |
$73 |
| 2021-09-30 |
$68 |
| 2021-06-30 |
$64 |
| 2021-03-31 |
$33 |
| 2020-12-31 |
$33 |
| 2020-09-30 |
$33 |
| 2020-06-30 |
$34 |
| 2020-03-31 |
$52 |
| 2019-12-31 |
$55 |
| 2019-09-30 |
$54 |
| 2019-06-30 |
$58 |
| 2019-03-31 |
$55 |
| 2018-12-31 |
$54 |
| 2018-09-30 |
$53 |
| 2018-06-30 |
$51 |
| 2018-03-31 |
$50 |
| 2017-12-31 |
$49 |
| 2017-09-30 |
$49 |
| 2017-06-30 |
$38 |
| 2017-03-31 |
$39 |
| 2016-12-31 |
$38 |
| 2016-09-30 |
$40 |
| 2016-06-30 |
$38 |
| 2016-03-31 |
$35 |
| 2015-12-31 |
$33 |
| 2015-09-30 |
$34 |
| 2015-06-30 |
$31 |
| 2015-03-31 |
$35 |
| 2014-12-31 |
$33 |
| 2014-09-30 |
$30 |
| 2014-06-30 |
$29 |
| 2014-03-31 |
$28 |
| 2013-12-31 |
$26 |
| 2013-09-30 |
$27 |
| 2013-06-30 |
$24 |
| 2013-03-31 |
$25 |
| 2012-12-31 |
$19 |
| 2012-09-30 |
$17 |
| 2012-06-30 |
$24 |
| 2012-03-31 |
$24 |
| 2011-12-31 |
$24 |
| 2011-09-30 |
$29 |
| 2011-06-30 |
$27 |
| 2011-03-31 |
$22 |
| 2010-12-31 |
$22 |
| 2010-09-30 |
$18 |
| 2010-06-30 |
$19 |
| 2010-03-31 |
$18 |
| 2009-12-31 |
$18 |
| 2009-09-30 |
$21 |
| 2009-06-30 |
$21 |
| 2009-03-31 |
$20 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$2.953B |
$2.236B |
|
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
|
